Article
Publicly Available
Frontmatter
Published/Copyright:
May 29, 2014
Published Online: 2014-5-29
Published in Print: 2014-6-1
©2014 by Walter de Gruyter Berlin/Boston
Articles in the same Issue
- Frontmatter
- Guest Editorial and News
- Cardiovascular nanomedicine
- News from the European Foundation for Nanomedicine (CLINAM): The 2014 CLINAM Summit
- What’s up in nanomedicine for cardiovascular diseases?
- Review Articles
- Cardiovascular therapy through nanotechnology – how far are we still from bedside?
- The simultaneous systematic analysis approach for personalized management of cardiovascular diseases
- Anti-inflammatory mediators for molecular imaging of atherosclerosis
- Perspectives
- Atherosclerotic disease and management challenges with nanomedicine: EU FP7 NMP funded “NanoAthero” and “CosmoPHOS-nano” large-scale projects
Articles in the same Issue
- Frontmatter
- Guest Editorial and News
- Cardiovascular nanomedicine
- News from the European Foundation for Nanomedicine (CLINAM): The 2014 CLINAM Summit
- What’s up in nanomedicine for cardiovascular diseases?
- Review Articles
- Cardiovascular therapy through nanotechnology – how far are we still from bedside?
- The simultaneous systematic analysis approach for personalized management of cardiovascular diseases
- Anti-inflammatory mediators for molecular imaging of atherosclerosis
- Perspectives
- Atherosclerotic disease and management challenges with nanomedicine: EU FP7 NMP funded “NanoAthero” and “CosmoPHOS-nano” large-scale projects